USAQ

QHSLab, Inc.
—

Company Information

Company Name
QHSLab, Inc.
CIK
CIK0000856984
Category
Non-accelerated filer<br>Smaller reporting company
Ticker: Exchange
USAQ: OTC
Fiscal Year End
December 31
Owner Organization
08 Industrial Applications and Services
SIC
3841
SIC Description
Surgical & Medical Instruments & Apparatus
Ticker
USAQ

SEC filing data through

Insider Sentiment

Last purchase
—
Last sale
—
Shares purchased (TTM)
0
Shares sold (TTM)
0
Buy ratio (TTM)—

Institutional Sentiment

As of
2021-09-30
Institutional shares owned
2
Shares outstanding
8,646,399
Ownership
0.00%

Earnings Market Reaction

Filing date
2026-08-12
Price on filing date
—
1-month reaction
0.00%
3-month reaction
…
Drift continued4/11 (36%)
Faded / reversed7/11 (64%)

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets
Cash And Cash Equivalents At Carrying Value001000000000
Accounts Receivable Net Current000000000000
Assets Current
Assets Current111000000000
Inventory Net000000000000
Prepaid Expense And Other Assets Current00000000000-
Other Prepaid Expense Current----------00
Assets Noncurrent
Capitalized Software Development Costs For Software Sold To Customers----------00
Capitalized Computer Software Net------00000-
Finite Lived Intangible Assets Net111111111111
Assets222222222222
Liabilities And Stockholders Equity
Accounts Payable Current000000000000
Liabilities Current
Liabilities Current000222222222
Other Liabilities Current000000000000
Loans Payable Current-0000000001-
Short Term Borrowings----------10
Convertible Notes Payable Current--0111111111
Long Term Loans Payable--0----0----
Liabilities Noncurrent
Liabilities Noncurrent--0----0----
Liabilities001222222222
Common Stock Value000000000000
Stockholders Equity
Additional Paid In Capital666444444444
Stockholders Equity222-1-1-1-1-0-0-0-0-0
Retained Earnings Accumulated Deficit-4-4-4-4-4-4-4-4-4-4-4-4
Liabilities And Stockholders Equity222222222222
Preferred Stock Shares Authorized101010101010101010101010
Preferred Stock Par Or Stated Value Per Share----------0.250.25
Common Stock Shares Authorized900900900900900900900900900900900900
Common Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Common Stock Shares Issued15151511111111101010109
Shares Outstanding15151511111111101010109

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

QHSLab, Inc. (USAQ) — SEC Financial Statements & Analysis

QHSLab, Inc. (USAQ) is a surgical & medical instruments & apparatus company, incorporated in NV. QHSLab, Inc. trades on OTC as: USAQ. QHSLab, Inc. (USAQ)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, QHSLab, Inc. carries a market cap of $3.98M, a P/E ratio of 7.60x, a P/B ratio of 2.56x, a P/S ratio of 1.32x, an enterprise value of $3.67M, and an EV/EBITDA multiple of 23.69x. On profitability, it posts a gross margin of 67.70%, an operating margin of 2.74%, a net margin of 17.37%, a Return on Equity (ROE) of 114.59%, a Return on Assets (ROA) of 28.76%, and a Return on Invested Capital (ROIC) of 7.80%. Per share, it reports EPS of $0.03, diluted EPS of $0.02, free cash flow per share of $-0.01, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 24.61% year-over-year, net income growth of -241.50% year-over-year, and EPS growth of -206.19% year-over-year. On the balance sheet, it maintains a current ratio of 1.82x, a quick ratio of 1.76x, working capital of $307.11K, a debt-to-equity ratio of 0.24x, a debt ratio of 0.19, an interest coverage ratio of 0.68x, free cash flow of $-107.43K (TTM), and net debt of $-317.39K. Figures sourced from SEC EDGAR.

Market Cap
$3.98M
P/E TTM
7.60x
EPS TTM
$0.03
P/B TTM
2.56x
ROE TTM
114.59%
ROA TTM
28.76%
Debt To Equity
0.24x
Free Cash Flow TTM
$-107.43K
Net Revenue TTM Growth 1Y
24.61%

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is QHSLab, Inc. in?

QHSLab, Inc. (USAQ) operates in the Surgical & Medical Instruments & Apparatus industry.

What exchange does USAQ trade on?

QHSLab, Inc. (USAQ) trades on the OTC.

Where is QHSLab, Inc. incorporated?

QHSLab, Inc. is incorporated in NV.

When was QHSLab, Inc. (USAQ)'s most recent SEC filing?

QHSLab, Inc. (USAQ)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.

What is USAQ's market cap?

QHSLab, Inc. (USAQ) has a market capitalization of $3.98M as of 2026-06-30.

What is USAQ's P/E ratio?

QHSLab, Inc. (USAQ)'s trailing twelve month P/E ratio is 7.60x as of 2026-06-30.

What is USAQ's EPS (earnings per share)?

QHSLab, Inc. (USAQ)'s trailing twelve month EPS is $0.03 as of 2026-06-30.

What is USAQ's ROE (return on equity)?

QHSLab, Inc. (USAQ)'s trailing twelve month Return on Equity (ROE) is 114.59% as of 2026-06-30.

What is USAQ's ROA (return on assets)?

QHSLab, Inc. (USAQ)'s trailing twelve month Return on Assets (ROA) is 28.76% as of 2026-06-30.

What is USAQ's ROIC (return on invested capital)?

QHSLab, Inc. (USAQ)'s trailing twelve month Return on Invested Capital (ROIC) is 7.80% as of 2026-06-30.

What is USAQ's EV/EBITDA?

QHSLab, Inc. (USAQ)'s trailing twelve month EV/EBITDA is 23.69x as of 2026-06-30.

Wall Street's data.
Main Street's price.